CK-18 fragments have been validated as a marker of NASH in many studies and it has even been recognized as the most promising noninvasive test for diagnosing and managing NASH in recent NAFLD guidelines [15]. Here, KRT18 is linked to metabolic dysfunction-associated steatohepatitis.